1. NOLUS: a predictive model to identify Basal-like and HER2-enriched intrinsic subtypes based on estrogen receptor (ER), progesterone receptor (PR) and Ki67 immunohistochemistry (IHC) in hormone receptor-positive/HER2-negative (HR+/HER2–) breast cancer (BC). (April 2018) Authors: Pascual, T.; Martín, M.; Pare, L.; Alba, E.; Rodríguez-Lescure, A.; Perrone, G.; Cortés, J.; Morales, S.; Lluch, A.; Urruticoechea, A.; Galván, P.; Rodríguez, A.; Chic, N.; Righi, D.; Cejalvo, J.M.; Tonini, G.; Adamo, B.; Vidal, M.; Muñoz, M.; Prat, A. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-1332 Early menopause induced by oncological treatments in breast and cervical cancer. (May 2022) Authors: Ching-López, R.; Vargas, P.; Rodríguez, S.; Cámara, L.; Galván, P.; Ruiz, A.M.; Zurita, M. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗